Byron Chemical Company, Inc. is a privately held firm, established in 1947. We operate within the pharmaceutical industry as sales, marketing, and regulatory agents for international manufactures.
Byron has established two groups: a group specializing in active pharmaceutical ingredients (APIs) and a group specializing in finished dose products (FDP). Byron has determined that because of the very different needs customers have in these two areas, expert attention is necessary. The API group includes Jake Ter Avest, Victor Rosenzweig and Adria Keleman. The FDP group includes Dwayne Sharpe and Nicholas Cola.
As sales and regulatory agents, we facilitate the entire product import and distribution process, maintaining compliance with applicable regulations.
Additional services include:
Product Registrations and Licenses
New Distribution & Placement
Product Lifecycle Management
Contract Development
Areas of Operation
The Byron Chemical business team functions internationally, serving suppliers and customers from across the world. Our knowledge of each global region enables us to represent our partners’ interests for a variety of requirements. While the United States represents our primary market, our reach includes all major regions worldwide.
Clients
After more than 60 years in the pharmaceutical and healthcare industry, Byron Chemical continues to service the needs of the pharmaceutical value chain. Our client base involves active pharmaceutical ingredients , dosage forms, regulatory, production, and consulting services. As a pioneer in this industry, we still do business with many of our original clients, which is a true testament to our ability to create partnerships. The Byron Chemical name and reputation spans generations; and when you think Byron Chemical, we invite you to think: “time-tested service, support, and creativity.”
United States
